NSE: EMCURE - Emcure Pharmaceuticals Ltd

Rentabilität für sechs Monate: -28.29%
Dividendenrendite: 0.00%

Aktionsplan Emcure Pharmaceuticals Ltd

de.porti.ru1600.001600.001400.001400.001200.001200.001000.001000.00800.00800.00Aug '24Aug '24Sep '24Sep '24Okt '24Okt '24Nov '24Nov '24Dez '24Dez '2420252025Feb '25Feb '25Mär '25Mär '25Apr '25Apr '25
SVG speichern
PNG speichern
CSV speichern

Über das Unternehmen Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, and other areas, as well as vitamins, minerals, and nutrients.

weitere details
The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

ISIN INE168P01015
Валюта inr
Сайт https://www.emcure.com
Цена ао 1025.55
Preisänderung pro Tag: 0% (1072.4)
Preisänderung pro Woche: +0.9603% (1062.2)
Preisänderung pro Monat: +9.81% (976.6)
Preisänderung über 3 Monate: -26.45% (1458.15)
Preisänderung über sechs Monate: -28.29% (1495.5)
Preisänderung seit Jahresbeginn: -21.14% (1359.9)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 0 0
Rentabilität Ebitda, % 0 0
Rentabilität EPS, % 0 0
Gesamt: 0
Weitere Details

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Satish Ramanlal Mehta CEO, MD & Executive Director 1951 (74 Jahr)
Mr. Tajuddin Sabir Shaikh Chief Financial Officer
Mr. Samit Satish Mehta President of Operations & Whole-Time Director 1982 (43 Jahr)
Dr. Mukund Keshao Gurjar Chief Scientific Officer & Whole-Time Director 1952 (73 Jahr)
Mr. Sunil Rajanikant Mehta Executive Director of Projects & Whole-Time Director 1963 (62 Jahr)
Ms. Namita Vikas Thapar Executive Director of India Business & Whole-Time Director 1977 (48 Jahre)
Mr. Chetan Rajendra Sharma Company Secretary & Compliance Officer 1988 (37 Jahre)
Mr. Naveen Soni Director of Corporate Communications & Public Relations
Mr. Vikas Madan Thapar President of Corporate Development, Strategy & Finance 1976 (49 Jahre)
Mr. Rajesh Nair Executive Vice President of Human Resources

Adresse: India, Pune, Plot No. P-1 and P-2 - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.emcure.com